Home β€Ί Healthcare β€Ί Biotechnology β€Ί Cell Banking Outsourcing Market

Cell Banking Outsourcing Market - Strategic Insights and Forecasts (2026-2031)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

🎯

Cell Banking Outsourcing Market Highlights

Biotech companies are increasingly outsourcing cell banking to meet growing therapy demands.
Asia-Pacific governments are investing heavily, driving regional dominance in cell banking outsourcing.
Regulatory bodies are enforcing stricter standards, ensuring higher quality and compliance in services.
Cell-based therapy developers are demanding reliable, well-characterized cell lines for advanced treatments.

Cell Banking Outsourcing Market Size:

Cell Banking Outsourcing Market is expected to grow at a 15.02% CAGR, increasing to USD 24.437 billion in 2031 from USD 10.556 billion in 2025.

Cell Banking Outsourcing Market Trends:

Cell banking outsourcing consists of a diverse array of services that encompass essential activities like the storage, collection, characterization, and testing of cells, cell lines, and tissues. It offers cell lines, cells, and tissues for research and development, as well as biopharmaceutical production. Cell banks aim to provide maximum efficacy and minimize adverse events. The cell banking outsourcing market is primarily driven by the rapid growth of biotech industries and the increasing adoption of cell-based therapies.

Cell Banking Outsourcing Market Segmentation Analysis:

  • Emerging biotech industries drive the cell banking outsourcing market expansion.

Cell banking processes and preserves cells, typically stem cells, in controlled environments for future use in various medical treatments and research applications. Favorable Investments in cell banking can significantly boost the growth of the cell banking outsourcing market. For instance, in September 2021, LifeCell International, a leading provider of stem cell banking and reproductive testing services, secured Rs 225 crore in equity funding from OrbiMed Asia Partners. The raised capital would be instrumental in supporting the company's growth strategy for its various divisions, as well as expanding its range of tests in the genomic sector.

  • Increasing cell-based therapies drives the cell banking outsourcing market expansion.

Cell banking outsourcing is utilized in cell-based therapies to meet the growing demand for well-characterized and reliable cell lines, which are crucial for the development of advanced regenerative and personalized medicines. The expanding adoption of cell-based therapies stems from their potential to address unmet medical needs, provide personalized treatment options, and offer promising solutions for various diseases and conditions, driving significant growth in the cell banking outsourcing market. According to the American Society of Gene Cell Therapy, In the year 2022, the pipeline of gene, cell, and RNA therapies witnessed a notable growth of 7%, encompassing preclinical to pre-registration stages.

  • Regulatory compliance drive cell banking outsourcing market growth.

The cell banking industry is governed by stringent regulatory requirements aimed at guaranteeing the safety, efficacy, and traceability of biological materials utilized in pharmaceutical production. As a result, reputable cell banking outsourcing providers place great emphasis on adhering to rigorous quality and regulatory standards. By maintaining strict compliance and implementing robust processes, these providers instill confidence in pharmaceutical companies regarding the reliability and integrity of their cell banking services, thus fostering a trustworthy partnership that is essential for advancing research, development, and manufacturing activities in the pharmaceutical sector.

Cell Banking Outsourcing Market Geographical Outlook:

  • Asia-Pacific is expected to be the market leader

Asia Pacific will hold a significant share of the cell banking outsourcing market due to the improved government investments and initiatives aimed at fostering biotech industries and advancing cell-based therapies in the region. Hence, with substantial financial support and supportive policies, Asian-Pacific countries have cultivated a conducive environment for biotech companies to flourish, thereby increasing the demand for specialized cell banking services. In Feb 2023,  to boost domestic production of high-value formulations, critical APIs (Active Pharmaceutical Ingredients), and high-end medical devices, the government of India released Rs. 166 Crores in incentives under the PLI scheme for Pharmaceuticals encompassing various products, including cell-based or gene-therapy drugs.

Cell Banking Outsourcing Market Growth Drivers:

  • Confidentiality concerns restrain the cell banking outsourcing market growth.

The reluctance of biotech companies to engage in cell banking outsourcing stems from their concerns about sharing sensitive information and proprietary knowledge with external partners, primarily due to the perceived risk of data breaches or breaches of confidentiality. This hesitancy can act as a significant restraint for the cell banking outsourcing market growth, as companies prioritize safeguarding their intellectual property and maintaining control over critical biological assets. Addressing these confidentiality and security concerns through robust data protection measures and building trusted partnerships with outsourcing providers is crucial to fostering greater confidence in the outsourcing process and unlocking the full potential of the cell banking outsourcing market.

Cell Banking Outsourcing Market Company Products:

  • cGMP-compliant cell banking services: GBI offers comprehensive cGMP-compliant cell banking services, encompassing research, master, and working cell banks (RCB, MCB, and WCB). These banks are meticulously prepared using a controlled-rate freezing system and securely stored in cryogenic vapor-phase liquid nitrogen storage chambers. Each cell bank undergoes rigorous testing, adhering to the latest industry Points to Consider, ensuring the highest quality and regulatory compliance for the storage and preservation of valuable cell resources.

Cell Banking Outsourcing Companies:

  • Bio Outsource (Sartorious)

  • BSL Bioservice

  • Cryo-Cell International, Inc.

  • Charles River Laboratories

  • LifeCell

Cell Banking Outsourcing Market Scope:

Report Metric Details
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Companies
  • Sartorius AG
  • Cryosite Limited
  • Charles River Laboratories Inc.
  • Cryo-Cell International, Inc
  • GBI Biomanufacturing
  • Lonza Group
  • SGS SA
  • WuXi AppTec
  • Eurofins Scientific
  • SK Pharmteco Inc

Report Metric

Details

Cell Banking Outsourcing Market Size in 2025

USD 10.556 billion

Cell Banking Outsourcing Market Size in 2030

USD 21.682 billion

Growth Rate

CAGR of 15.48%

Study Period

2020 to 2030

Historical Data

2020 to 2023

Base Year

2024

Forecast Period

2025 – 2030

Forecast Unit (Value)

USD Billion

Segmentation

  • Type

  • Cell

  • Phase

  • Geography

Geographical Segmentation

North America, South America, Europe, Middle East and Africa, Asia Pacific

List of Major Companies in the Cell Banking Outsourcing Market

  • Bio Outsource (Sartorious)

  • BSL Bioservice

  • Cryo-Cell International, Inc.

  • Charles River Laboratories

  • LifeCell

Customization Scope

Free report customization with purchase

 

Cell Banking Outsourcing Market Segmentation

  • By Bank Type

    • Master Cell Bank

    • Working Cell Bank

  • By Cell Type

    • Stem Cell

    • Non-Stem Cell

  • By End-User

    • Pharmaceutical & Biotech Companies

    • Academic & Research Institutes

    • Others

  • By Geography

    • North America

      • USA

      • Canada

      • Mexico

    • South America

      • Brazil

      • Argentina

      • Others

    • Europe

      • Germany

      • France

      • United Kingdom

      • Spain

      • Others

    • Middle East and Africa

      • Saudi Arabia

      • UAE

      • Others

    • Asia Pacific

      • China

      • India

      • Japan

      • South Korea

      • Indonesia

      • Thailand

      • Others

Our Best-Performing Industry Reports:

Navigation:

REPORT DETAILS

Report ID:KSI061615812
Published:Jan 2026
Pages:148
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The cell banking outsourcing market is expected to reach a total market size of USD 21.682 billion by 2030.

Cell Banking Outsourcing Market is valued at USD 10.556 billion in 2025.

The cell banking outsourcing market is expected to grow at a CAGR of 15.48% during the forecast period.

Rising demand for cell-based therapies, increasing R&D in regenerative medicine, and cost-efficiency are key factors driving cell banking outsourcing market growth.

North America holds the largest share of the global cell banking outsourcing market.

Related Reports

Healthcare

Pre-Clinical CRO Market Size, Share, Opportunities, and Trends By Service Type (Toxicology Testing, Pharmacokinetics & Pharmacodynamics, Safety Pharmacology, Bioanalytical Services, In Vitro Testing, In Vivo Models), By Drug Type (Biologics, Vaccines, Small Molecules, Cell/Gene Therapies), By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Rare Diseases, Others), By End-User (Biotech Startups, Large Pharma, Medical Device Companies, Academic/Government Institutes), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Clinical CRO Market Size, Share, Opportunities, And Trends By Clinical Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV [Post-Marketing Surveillance]), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases, Others), By Service Category (Clinical Operations And Monitoring, Data And Analytics, Regulatory And Safety, Real-World Evidence [RWE] & Health Economics Outcomes Research [HEOR]), By Client Type (Large Pharma, Small & Mid Biotech, Medical Device Companies, Government And Academic Institutes, CDMOs), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Industrial Biotechnology Market Size, Share, Opportunities, And Trends By Technology (Fermentation, Genetic Engineering, Others), By Raw Materials (Enzymes, Microorganisms, Bacteria, Yeast, Others), By Application (Biofuel, Biopolymer, Biochemicals, Biomedicines, Others), By End-User (Pharmaceutical, Food & Beverage, Chemical, Energy & Power, Textiles, Others), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Botulinum Toxins Market - Strategic Insights and Forecasts (2025-2030)

Jan 2026
View All Reports